Why PHVS rose 26.7% on Sep 8 2026: positive pivotal trial data
PHVS+26.7%on Tue Sep 8 2026
Pharvaris N.V. Ordinary Shares was up 26.7% on the day at $44.66, ranked #2 on 90.5× its usual five-minute volume, when TapeRank recorded this spike at 07:16 ET during the pre-market session.
THE DAY ON THE LIST · 1 EVENT
- 07:16 ETMOVER · PRE-MARKET
$44.66 · ▲ 26.7% ON THE DAY · 90.5× 5M RVOL · RANK #2
JUSTIFIEDCONFIDENCE5/5Pharvaris shares are up roughly 25% pre-market after announcing positive topline data from the CHAPTER-3 pivotal study of deucrictibant XR for HAE attack prophylaxis, a binding, quantifiable clinical readout rather than a vague partnership. The pullback in the last five minutes reflects normal profit-taking and volatility after the initial pop on heavy volume.
WHYA positive pivotal phase 3 readout is a major binary catalyst for a clinical-stage biotech, and a 25% move is proportionate to de-risking a lead pipeline asset ahead of potential regulatory filing.ANALYZED 07:17 ET · <1 MIN AGO · ANTHROPIC/CLAUDE-SONNET-5THE ROW AND SESSION LEVELS AT 07:16 ET
LAST44.66DAY▲ 26.7%5 MIN▼ 2.04%5M RVOL90.5×5M $VOL$1.4MFLOAT*65.4MRANK#2SESSIONPRE-MARKETVWAP43.44HOD48.00LOD36.95OR HIGH—OR LOW—PREV CLOSE35.25PM HIGH48.00PM LOW36.95GAP▲ 29.79% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
THE SESSION
- 09:30 ETOpened at $40.96, +16.2% on the previous close of $35.25
- 09:33 ETRegular-session high, $43.25
- 13:37 ETRegular-session low, $37.60
- 15:59 ETLast trade of the regular session, $37.75, +7.1% on the previous close of $35.25
- Volume: 5.5M shares in regular hours, 619K before the open
PHVS was already running premarket, up about 27% near $44.66 by 07:16 ET, with TapeRank tying the move to positive pivotal CHAPTER-3 trial data for deucrictibant XR in HAE attack prophylaxis, a binding clinical readout it judged fully justified at the highest confidence. Shares opened the regular session up 16.2% at $40.96, spiked to $43.25 by 09:33 ET, then faded through the day to a low of $37.60 at 13:37 ET on heavy volume. The stock closed the session at $37.75, finishing up 7.1% from the prior close with no halts recorded.
WRITTEN THU OCT 15 2026 17:42 ET BY ANTHROPIC/CLAUDE-SONNET-5 FROM THE FACTS ON THIS PAGE
FILINGS · 24H BEFORE THE MOVE
- 02:51 ET6-K — Foreign issuer reportSEC 6-K
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list